Founded by the enterprising duo Chirag Maheshwari and Prateek Maheshwari in 2022, Peping, an emerging player in the healthtech landscape, has successfully garnered $400,000 in an investment round spearheaded by Better Capital. The financing also welcomed contributions from a host of seasoned angel investors, including luminaries such as Kunal Shah, Sandeep Kumar Dinodiya, Ganesh Balakrishnan, and Shubham Mishra.
According to a public announcement from Peping, the new infusion of capital is earmarked for several pivotal initiatives. These include bolstering its technological architecture, augmenting its team, and reserving funds for inventive experiments that could redefine the approach to patient-centric care.
Based in Bengaluru, Peping aims to revolutionize the medical field by developing a fully digitized clinical experience for patients. Focusing on various gastrointestinal and liver issues such as Irritable Bowel Syndrome (IBS), Gastroesophageal Reflux Disease (GERD), Gastritis, and Fatty Liver, the startup is working to provide targeted dietary guidelines and lifestyle interventions.
Peping’s mission is to alter the standard operating protocol of medical care by offering personalized treatment plans. These plans consider an array of factors like individual lifestyle and diagnostic test results to pinpoint and address the root causes of various health conditions. This is not just an incremental change; it represents a fundamental shift in the methodology of healthcare delivery by transforming it into a truly patient-centered practice.
To achieve this transformative change, the newly acquired funds will be instrumental. With the primary focus on advancing its technical capabilities, Peping is set to invest in innovative software and hardware solutions that will enhance user experience and improve treatment outcomes. An advanced, easy-to-use interface is crucial in today’s digital age, where immediacy and accessibility can make a marked difference in how healthcare is perceived and utilized.
Team expansion is another cornerstone of Peping’s growth strategy. Skilled professionals from various domains like software development, healthcare consulting, and data analytics will be brought on board. These additions will help the company develop a more comprehensive and intelligent solution, informed by cross-disciplinary insights.
Interestingly, a part of the newly-raised capital is reserved for what the company refers to as ‘creative experiments.’ While details are sparse, it’s understood that these would be breakthrough approaches to reimagine how healthcare is delivered, especially concerning lifestyle and diet-based interventions. The experiments aim to bring about new paradigms in treating diseases by intervening at the foundational lifestyle level, thereby providing lasting solutions rather than short-term fixes.
The lead investor, Better Capital, is no stranger to backing promising startups. Having raised its inaugural fund of $15.2 million in November 2021, the micro-venture capital firm has been actively nurturing businesses in their infancy across diverse sectors. Its portfolio boasts more than 60 fledgling companies, including names like Teachmint, Slice, Rupeek, Kutumb, Filo, Airmeet, Khatabook, Rupifi, and OTO. The investment in Peping aligns well with Better Capital’s overarching strategy to encourage and support pre-seed and seed-stage startups in India.
In summary, Peping’s recent funding round offers more than just financial breathing room; it serves as a testament to the startup’s potential to disrupt the traditional healthcare system. The Bengaluru-based healthtech venture is strategically poised to change the landscape of patient-centric care, courtesy of its dynamic team, innovative technology, and the substantial backing from an array of savvy investors. As Peping moves forward, its multi-pronged approach—technical advancement, team growth, and daring experimentation—may well redefine how we understand and manage lifestyle-related health issues in the years to come.
